Articles related to life sciences
Colleen Hoke, Don Lazas are fresh off Frist-backed Series A, now at 12 centers and running.
[updated] Frist discloses details about what's under the hood of the healthtech startup now in stealth mode.
A rigorous study of TN lifesciences is afoot and advocates are clearly positioning to push for public and private support.
The word is just getting out about new entrant in Tennessee biopharm ecosystem.
Healthcare IT, solutions and consulting provider has apparently passed a revenue milestone.
Former BioMimetic Therapeutics executives at center of new initiatives.
[updated] A baker's dozen oughta-reads on startups and capital from around the state.
VTC A fresh assay has led to new focus and renewed vision for regional service and leadership.
Cautious handling by proponents seems likely to advance state programs, stepwise.
Developers studying HudsonAlpha and other innovation centers.
[Updated] Team says rapid Angel-investor enlistment is one reason this is a 'W' for region's LifeSciences
[updated] Williamson County aims to breed its Tech sector, leverages NEC resources
President James Stover says company has good talks with potential strategic partners
[EMIDS update Dec. 5, 2013] Maybe it's time to focus on something more than our reported shortage of coders
Entrepreneur says she's found more than a good lease in Nashville
The rising Tide in Alabama may lift some small Tennessee ventures along with it.
Scholar and entrepreneur will co-found molecular diagnostics startup in Nashville
A Brailer exec joins regional VC, Nutraceuticals' Grindstaff, Investor Days ahead for incubators, Amazon thing gets awkward and more
Two pharmas are already aboard and other allies for accelerating drug development may be in-the-offing
Another 'complaining' serial entrepreneur is having trouble retiring, as one venture happily leads to another
Veteran recruiters in life sciences, engineering and telecom have started their own consultancies in Franklin.
Nashville and Tennessee are quickly becoming year-round innovation venues, as this sampling of events makes clear
Pfizer, Kleiner Perkins, et al, have given another vote of confidence to this Bay Area-based venture aiming at MLS, Cancer and other diseases
Education Networks..StudioNow..Biotechies...Scripps Interactive..Aegis Health... VU's science reports, and more..
Lynch cites workforce challenges and the need for more collaboration throughout the region as essential to lift Nashville from lower tier of life-science centers
Nanotechnology innovation promises better drug delivery for treatment of numerous diseases
At left, Dr. Harry Jacobson
Technology-enterprise advocate believes life-sciences sector cannot advance without stronger leadership
[updated] Though their faith in the future may vary, retained executive-search professionals are investing energy in Bio and related fields.
The yet-to-be-operational TNInvestco capital-formation program seems to have kindled fresh interest in key sectors
Departing exec says she sought 'sense of urgency', while interim chairman says he hopes TBA will find 'someone like Leslie' to help group become 'more relevant'
[UPDATED Aug. 11, 6:53 a.m.] Cumberland Pharmaceuticals' IPO filing became effective yesterday and trades today as CPIX, 27 months after the shelf registration and 20 subsequent amendments
With former VC hired to lead program, grant for entrepreneurship helps flesh-out tech-development ecosystem
By enlisting a squad of scientists based here, this California firm has created a pathway of its own into Nashville's fledgling biotechnology community
The Pitt Hyde-founded life-sciences investor will soon be on the prowl again, in a target-rich marketplace of down-valued companies
TTDC presses ahead on numerous fronts, with a deadline looming just over the horizon, amid a rough economy, and political changes
Life-sciences company says it's still focused on move, but sales lag and economic conditions creating headwind
TTDC lands prominent healthcare CEO, scientist and policy influential to help navigate the shores of business, academe and government
At deal-making summit, investment bankers and others say focus on regulatory pressure for cost-reductions, rather than on next President
While critics sound off and Biotech targets General Assembly, an economy-shaping executive keeps pushing education and innovations